FindTrial
Sign In

Assessment of the quality of the automatic stimulus electrodiagnosis test to detect diseases in peripheral nerves

Reproducibility Assessment of an automated system for neuromuscular electrophysiological analysis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
REBEC
Registry ID
RBR-6rtdrn
Enrollment
Unknown
Registered
2020-08-20
Start date
2020-08-24
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Polyneuropathies

Interventions

A prospective observational study will be carried out to assess the clinimetrics properties of the stimulus electrodiagnosis test (SET). 10 healthy participants will be studied who will serve as contr
E01.370.405.255
Q20.010

Sponsors

Paulo Eugênio Silva
Lead Sponsor
Instituto de Gestão Estratégica de Saúde do Distrito Federal
Collaborator

Eligibility

Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Healthy. Individuals with no history of neuromuscular or orthopedic disease; Intensive care unit. Patients with traumatic brain injury; Sedated patients with at least 6 days of invasive mechanical ventilation; Participants aged between 18 and 60 years.

Exclusion criteria

Exclusion criteria: Healthy. Pregnant women; Individuals with skin lesions in the area to be assessed; Intensive care unit. Pregnant women; Patients with skin lesions and or fractures in the area to be assessed; Use of neuromuscular blocker on the day of the assessment; Patients with brain death.

Design outcomes

Primary

MeasureTime frame
a) Reproducibility of the stimulus electrodiagnosis test (SET) manual and automated; ;b) SET sensitivity and specificity for the diagnosis of critical illness polyneuromyopathy to ultrasound as the gold standard.—

Secondary

MeasureTime frame
a) Association and collinearity between chronaxia and intensity-duration curve with clinical characteristics (physiological severity and trauma score at admission (SAPS III and ISS), physiological severity score at the day of assessment (SOFA), presence of sepsis, use of vasopressor drugs, blood glucose, use of corticosteroids, etc.), as well as, with clinical outcomes (duration of mechanical ventilation, length of ICU stay, mortality, etc.). ;b) Association between the quality of evoked contraction and two points of pulse width in the intensity-duration curve (500 us and chronaxia);—

Countries

Brazil

Contacts

Public ContactPaulo Silva

Instituto de Gestão Estratégica de Saúde do Distrito Federal

pauloeugenio.bsb@gmail.com+55-61-996864850

Outcome results

None listed

Source: REBEC (via WHO ICTRP)